Andreas Brønden

797 total citations
36 papers, 619 citations indexed

About

Andreas Brønden is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Andreas Brønden has authored 36 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Surgery and 11 papers in Oncology. Recurrent topics in Andreas Brønden's work include Diabetes Treatment and Management (22 papers), Drug Transport and Resistance Mechanisms (11 papers) and Metabolism, Diabetes, and Cancer (8 papers). Andreas Brønden is often cited by papers focused on Diabetes Treatment and Management (22 papers), Drug Transport and Resistance Mechanisms (11 papers) and Metabolism, Diabetes, and Cancer (8 papers). Andreas Brønden collaborates with scholars based in Denmark, Sweden and France. Andreas Brønden's co-authors include Filip K. Knop, Tina Vilsbøll, David P. Sonne, Mikkel Christensen, Jens J. Holst, Jens F. Rehfeld, Morten Hansen, Ulrich Rohde, Lærke S. Gasbjerg and Louise Vedtofte and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Andreas Brønden

35 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Brønden Denmark 17 352 246 214 118 100 36 619
Renee Amori United States 5 772 2.2× 296 1.2× 306 1.4× 150 1.3× 78 0.8× 7 893
Colleen Craig United States 12 202 0.6× 254 1.0× 131 0.6× 21 0.2× 261 2.6× 16 567
Maria Elena Lunati Italy 11 332 0.9× 171 0.7× 159 0.7× 22 0.2× 101 1.0× 27 640
Carol Wilcock United Kingdom 8 290 0.8× 480 2.0× 517 2.4× 108 0.9× 157 1.6× 9 903
Shizuka Kaneko Japan 11 847 2.4× 291 1.2× 400 1.9× 21 0.2× 188 1.9× 23 1.0k
Fred Yang United States 9 771 2.2× 300 1.2× 386 1.8× 33 0.3× 50 0.5× 17 867
H A Carmichael United Kingdom 13 87 0.2× 152 0.6× 45 0.2× 61 0.5× 72 0.7× 19 604
Song Lu China 16 255 0.7× 136 0.6× 128 0.6× 31 0.3× 105 1.1× 23 662
Judi A. McNulty United States 9 129 0.4× 118 0.5× 159 0.7× 134 1.1× 98 1.0× 9 390
Ben A. Kappel Germany 12 88 0.3× 77 0.3× 278 1.3× 25 0.2× 121 1.2× 20 441

Countries citing papers authored by Andreas Brønden

Since Specialization
Citations

This map shows the geographic impact of Andreas Brønden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Brønden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Brønden more than expected).

Fields of papers citing papers by Andreas Brønden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Brønden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Brønden. The network helps show where Andreas Brønden may publish in the future.

Co-authorship network of co-authors of Andreas Brønden

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Brønden. A scholar is included among the top collaborators of Andreas Brønden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Brønden. Andreas Brønden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoffmann, Elke, Eva Greibe, Lasse K. Bak, et al.. (2025). Evaluation of antiseizure medication concentration ranges in blood samples using an automated big data approach. Epilepsia. 66(6). 1888–1898.
2.
Kelstrup, Louise, David P. Sonne, Andreas Brønden, et al.. (2024). Increased gallbladder emptying and reduced GLP ‐1 response in pregnancy with and without gestational diabetes mellitus. Diabetes Obesity and Metabolism. 27(2). 697–709. 2 indexed citations
3.
Brønden, Andreas, et al.. (2024). The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse Effects. Patient Preference and Adherence. Volume 18. 373–382. 17 indexed citations
4.
Forman, Julie Lyng, et al.. (2024). Expression of Bile Acid Receptors and Transporters Along the Intestine of Patients With Type 2 Diabetes and Controls. The Journal of Clinical Endocrinology & Metabolism. 110(3). e660–e666. 3 indexed citations
5.
Brønden, Andreas, et al.. (2024). The bile–gut axis and metabolic consequences of cholecystectomy. European Journal of Endocrinology. 190(4). R1–R9. 3 indexed citations
6.
Gasbjerg, Lærke S., Andreas Brønden, Signe Stensen, et al.. (2024). The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial. European Journal of Endocrinology. 191(2). 192–203. 3 indexed citations
7.
Nygaard, Birte, Martin Krakauer, Andreas Brønden, et al.. (2023). Effects of levothyroxine substitution therapy on hunger and food intake in individuals with hypothyroidism. Endocrine Connections. 12(10). 5 indexed citations
8.
9.
Brønden, Andreas, Julie Lyng Forman, Anne Haaber, et al.. (2022). Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial. ˜The œLancet. Gastroenterology & hepatology. 7(10). 922–931. 29 indexed citations
10.
Sonne, David P., Jens J. Holst, Jens F. Rehfeld, et al.. (2022). Enterohepatic, Gluco-metabolic, and Gut Microbial Characterization of Individuals With Bile Acid Malabsorption. SHILAP Revista de lepidopterología. 1(3). 299–312. 8 indexed citations
11.
Brønden, Andreas, Emil List Larsen, Kristian Karstoft, et al.. (2019). Changes in oxidative nucleic acid modifications and inflammation following one-week treatment with the bile acid sequestrant sevelamer: Two randomised, placebo-controlled trials. Journal of Diabetes and its Complications. 34(2). 107446–107446. 4 indexed citations
12.
Brønden, Andreas, et al.. (2019). Remission of Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide. Gastroenterology. 157(2). 569–571. 19 indexed citations
13.
Brønden, Andreas & Filip K. Knop. (2019). Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology. The Journal of Clinical Endocrinology & Metabolism. 105(1). 362–373. 18 indexed citations
14.
Hausner, Hélène, Andreas Brønden, David P. Sonne, et al.. (2018). Effects of liraglutide on gallbladder emptying: A randomized, placebo‐controlled trial in adults with overweight or obesity. Diabetes Obesity and Metabolism. 20(11). 2557–2564. 42 indexed citations
15.
Brønden, Andreas, Filip K. Knop, & Mikkel Christensen. (2017). Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide. Clinical Pharmacokinetics. 56(7). 719–731. 19 indexed citations
16.
Brønden, Andreas, Ulrich Rohde, Jens F. Rehfeld, et al.. (2017). Single-Dose Metformin Enhances Bile Acid–Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 102(11). 4153–4162. 34 indexed citations
17.
Brønden, Andreas, et al.. (2017). Cardiovascular safety and benefits of GLP-1 receptor agonists. Expert Opinion on Drug Safety. 16(3). 351–363. 27 indexed citations
18.
19.
Rohde, Ulrich, David P. Sonne, Mikkel Christensen, et al.. (2016). Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses. The Journal of Clinical Endocrinology & Metabolism. 101(5). 2076–2083. 30 indexed citations
20.
Brønden, Andreas, et al.. (2015). Albiglutide for treating type 2 diabetes: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy. Expert Opinion on Drug Metabolism & Toxicology. 11(9). 1493–1503. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renee Amori Breakdown of academic impact, for papers by Colleen Craig Breakdown of academic impact, for papers by Maria Elena Lunati Breakdown of academic impact, for papers by Carol Wilcock Breakdown of academic impact, for papers by Shizuka Kaneko Breakdown of academic impact, for papers by Fred Yang Breakdown of academic impact, for papers by H A Carmichael Breakdown of academic impact, for papers by Song Lu Breakdown of academic impact, for papers by Judi A. McNulty Breakdown of academic impact, for papers by Ben A. Kappel
Rankless by CCL
2026